Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Cancers
Hossein TaghizadehGerald W Prager

Abstract

Recurrent/metastatic (R/M) head and neck cancers bear a poor prognosis. In this analysis, we examined the efficacy and the outcome of targeted therapy recommendations based on the patients' molecular tumor portrait after failure of all standard therapy options. In this single-center, real-world retrospective analysis of our platform for precision medicine, we analyzed the molecular profile of 50 patients diagnosed with R/M head and neck cancer. Tumor samples of the patients were examined using next-generation sequencing panels of mutation hotspots, microsatellite instability (MSI) testing, and immunohistochemistry (IHC). In 31 cases (62.0% of all patients), a molecular-driven targeted therapy approach was recommended. Eventually, 14 patients (28%) received the suggested targeted therapy. Six of fourteen patients (43%) achieved stable disease conditions and four patients (29%) experienced a progressive disease. The median time to treatment failure was 2.8 months. Therapy recommendations were significantly more often issued for men (p = 0.037) than for women. This analysis demonstrated that precision medicine provided the basis for molecular-driven therapy recommendations in over half of the patients with advanced therapy refract...Continue Reading

References

Mar 1, 1992·The Clinical Investigator·H MaierH Weidauer
Apr 30, 2011·Archives of Pathology & Laboratory Medicine·Jennifer L Hunt
Jun 10, 2011·European Journal of Gastroenterology & Hepatology·René LambertRengaswamy Sankaranarayanan
Oct 14, 2011·The New England Journal of Medicine·Dennis SlamonUNKNOWN Breast Cancer International Research Group
Apr 2, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hartmut KoeppenRobert L Yauch
Apr 29, 2014·The American Journal of Pathology·Pan ZhangHelen Fernandes
Nov 27, 2014·Archives of Pathology & Laboratory Medicine·Jeffrey W Prichard
Nov 15, 2016·The Journal of Laryngology and Otology·R Shaw, N Beasley
Jun 24, 2017·World Journal of Otorhinolaryngology - Head and Neck Surgery·Edmund A Mroz, James W Rocco
Mar 8, 2018·Journal of Dental Research·T Nonaka, D T W Wong
Jun 1, 2018·Current Protocols in Molecular Biology·Barton E SlatkoFrederick M Ausubel
Jul 11, 2018·World Journal of Oncology·Anil Kumar DhullVivek Kaushal
Nov 20, 2018·Oral and Maxillofacial Surgery Clinics of North America·Simran K Sindhu, Julie E Bauman
Apr 10, 2019·Trends in Cancer·Joshua D HortonDavid M Neskey
Apr 27, 2019·Frontiers in Cell and Developmental Biology·Madison CanningYan Cui
Jun 27, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L FerrisMaura L Gillison
Jul 17, 2019·Cell Death & Disease·Elham AlsahafiMahvash Tavassoli

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
biopsy
Assay

Clinical Trials Mentioned

NCT03088059

Software Mentioned

UPSTREAM
SPSS Statistics
Ion Reporter
MSI Analysis System

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Personalized Medicine
Hossein TaghizadehGerald W Prager
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
H MiyazatoS Koja
© 2021 Meta ULC. All rights reserved